Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Neurocrine Biosciences, Inc. (Neurocrine) is a biopharmaceutical company, engaged in the discovery, development and commercialization of innovative pharmaceutical products for the treatment of neurological and endocrine-related diseases and disorders. The company has developed many of its product candidates targeted at world's largest pharmaceutical markets such as endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders.
Global Market Direct's Neurocrine Biosciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company's major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the company's major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers' businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors' business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
Table Of Contents
Table Of Contents 2
List of Tables 2
List of Figures 2
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Sector, 2004 to YTD 2009 6
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deal Details 8
Asset Purchase 8
Neurocrine Acquires Indiplon Royalty Stream From Wyeth 8
Partnerships 9
Neurocrine Biosciences Signs an Agreement With Dainippon Sumitomo Pharma 9
Neurocrine Biosciences and Pfizer Terminate Collaboration Agreement 10
Neurocrine Biosciences Entered into Licensing Agreement With Almirall Prodesfarma 11
Key Competitors 12
Key Employees 12
Locations And Subsidiaries 12
Head Office 12
Appendix 13
Methodology 13
About Global Markets Direct 13
Contact Us 13
Disclaimer 13
List of Tables
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare Deals By Type, 2004 to YTD 2009 4
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Neurocrine Biosciences, Inc., Deals By Sector, 2004 to YTD 2009 6
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2004 to YTD 2009 7
Neurocrine Acquires Indiplon Royalty Stream From Wyeth 8
Neurocrine Biosciences Signs an Agreement With Dainippon Sumitomo Pharma 9
Neurocrine Biosciences and Pfizer Terminate Collaboration Agreement 10
Neurocrine Biosciences Entered into Licensing Agreement With Almirall Prodesfarma 11
Neurocrine Biosciences, Inc., Key Employees 12
List of Figures
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2004 to YTD 2009 3
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2004 to YTD 2009 4
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2004 to YTD 2009 5
Neurocrine Biosciences, Inc., Pharmaceuticals & Healthcare, Deals by Sector, 2004 to YTD 2009 6